Maple Rock Capital Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,133,887
Closed -$13.8M 40
2025
Q3
$13.8M Sell
2,133,887
-5,674,600
-73% -$38.8M 0.54% 40
2025
Q2
$52M Buy
7,808,487
+1,010,987
+15% +$5.19M 2.55% 16
2025
Q1
$44M Buy
6,797,500
+1,497,500
+28% +$10.8M 1.61% 18
2024
Q4
$42.7M Buy
5,300,000
+3,235,100
+157% +$26.7M 1.28% 20
2024
Q3
$16.8M Buy
+2,064,900
New +$13.6M 0.48% 28

Other funds holding BHC

Maple Rock Capital Partners's BHC Position: Q4 2025 in Review

Maple Rock Capital Partners sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 2,133,887 shares — an estimated $13.8M sold.

Maple Rock Capital Partners first reported a position in BHC in Q3 2024 and held it in 5 quarters. The position peaked at $52M in Q2 2025. 235 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

  • Maple Rock Capital Partners reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
  • Maple Rock Capital Partners sold 2,133,887 Bausch Health shares in Q4 2025, an estimated $13.8M.
  • Maple Rock Capital Partners first reported a position in Bausch Health in Q3 2024 and held it in 5 quarters.
  • Maple Rock Capital Partners's Bausch Health position peaked at $52M in Q2 2025.
  • 235 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Maple Rock Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.